A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers, Pulmonary Arterial Hypertension

Interventions

DRUG: LTP
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals